Source
Integrated signatures define mutational processes in prostate cancer PRIMARY_TEXT
Retrieval by Galedra
FETCHED at 2026-09-29T00:07:23Z · https://www.nature.com/articles/s41586-026-10468-w?error=cookies_not_supported&code=88de34c0-d828-4eff-b992-8d09f5008272 · seq 15083
| Excerpt | Finding |
|---|---|
| Here we dissect the mutational processes shaping the genomes of 959 donors from the Pan Prostate Cancer Group and assess their clinical relevance. By integra... | not found — this server looked at the page and did not find the passage |
| In patients predicted to be sensitive (IMF6 > median), ARPI treatment was associated with a significantly reduced risk of treatment failure compared to taxan... | verbatim — the passage is on the page, character for character |
Claims from this source
No claims have been extracted from this source yet.
Locations
| Locator | Excerpt |
|---|---|
QUOTE {} | Here we dissect the mutational processes shaping the genomes of 959 donors from the Pan Prostate Cancer Group and assess their clinical relevance. By integrating de novo extracted single-base substitution, insertion–deletion and copy-num... |
QUOTE {} | In patients predicted to be sensitive (IMF6 > median), ARPI treatment was associated with a significantly reduced risk of treatment failure compared to taxane (hazard ratio = 0.21, 95% confidence interval (CI) = 0.05–0.79, P = 0.021, Wal... |